Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2018, Article ID 2840707, 4 pages
https://doi.org/10.1155/2018/2840707
Case Report

Acute Progressive Visual Loss in a Case of Acute Myeloid Leukemia: Challenges in the Utility of Molecular Tests in Early Diagnose of Cytomegalovirus Retinitis

1Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3Poostchi Eye Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Correspondence should be addressed to Omid Reza Zekavat; moc.liamg@tavakezo

Received 16 October 2017; Revised 27 December 2017; Accepted 2 January 2018; Published 31 January 2018

Academic Editor: Thomas R. Chauncey

Copyright © 2018 Ali Amanati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. L. Ian, K. M. D. Yeung, E. Cunningham, and N. Sen, “CMV retinitis: reduced incidence, still a threat,” Review of ophthalmology, vol. 23, no. 5, p. 58, 2016. View at Google Scholar
  2. A. Benova, M. Brichova, P. Svozilkova et al., “Cytomegalovirus retinitis in HIV negative patients-retrospective study,” Ceská a Slovenská Oftalmologie, vol. 69, no. 6, pp. 227–234, 2013. View at Google Scholar
  3. K. M. Downes, D. Tarasewicz, L. J. Weisberg, and E. T. Cunningham, “Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients—case report and comprehensive review of the literature,” Journal of Ophthalmic Inflammation and Infection, vol. 6, no. 1, p. 3, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Balansard, B. Bodaghi, N. Cassoux et al., “Necrotising retinopathies simulating acute retinal necrosis syndrome,” British Journal of Ophthalmology, vol. 89, no. 1, pp. 96–101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. E. Engstrom, G. N. Holland, T. P. Margolis et al., “The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS,” Ophthalmology, vol. 101, no. 9, pp. 1488–1502, 1994. View at Publisher · View at Google Scholar
  6. J. B. Ganatra, D. Chandler, C. Santos, B. Kuppermann, and T. P. Margolis, “Viral causes of the acute retinal necrosis syndrome,” American Journal of Ophthalmology, vol. 129, no. 2, pp. 166–172, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. M. H. Wong, G. C. Cheung, and S. P. Chee, “Posterior segment findings of ocular cytomegalovirus infection in immunocompetent patients,” Graefe’s Archive for Clinical and Experimental Ophthalmology, vol. 252, no. 11, pp. 1811–1816, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. T. al-Tweigeri, J. M. Nabholtz, and J. R. Mackey, “Ocular toxicity and cancer chemotherapy. A review,” Cancer, vol. 78, no. 7, pp. 1359–1373, 1996. View at Publisher · View at Google Scholar
  9. A. E. Omoti and C. E. Omoti, “Ocular toxicity of systemic anticancer chemotherapy,” Pharmacy Practice (Granada), vol. 4, no. 2, pp. 55–59, 2006. View at Publisher · View at Google Scholar
  10. E. Ashley, R. Lewis, J. Lewis, C. Martin, and D. Andes, “Pharmacology of systemic antifungal agents,” Clinical infectious diseases, vol. 43, no. 1, pp. 28–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. B. A. Cunha, “Antibiotic side effects,” Medical Clinics of North America, vol. 85, no. 1, pp. 149–185, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. S. D. Jaanus, “Ocular side effects of selected systemic drugs,” Optometry Clinics, vol. 2, no. 4, pp. 73–96, 1992. View at Google Scholar
  13. J. H. Pula and E. Eggenberger, “Posterior reversible encephalopathy syndrome,” Current Opinion in Ophthalmology, vol. 19, no. 6, pp. 479–484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Guiver, A. J. Fox, K. Mutton, N. Mogulkoc, and J. Egan, “Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients,” Transplantation, vol. 71, no. 11, pp. 1609–1615, 2001. View at Publisher · View at Google Scholar
  15. A. Lat and G. R. Thompson III, “Update on the optimal use of voriconazole for invasive fungal infections,” Infection and Drug Resistance, vol. 4, p. 43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. “Voriconazole vial side effects,” 2017, https://www.webmd.com/drugs/2/drug-63367/voriconazole-intravenous/details/list-sideeffects.
  17. S. Demir, H. Çeliker, A. Karaaslan et al., “Cytomegalovirus retinitis in three pediatric cases with acute lymphoblastic leukemia: case series and review of the literature,” Japanese Journal of Infectious Diseases, vol. 69, no. 6, pp. 534–538, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Orhan, B. Malbora, S. Akça Bayar, Z. Avcı, B. Alioğlu, and N. Özbek, “Ophthalmologic findings in children with leukemia: a single-center study,” Turkish Journal of Ophthalmology, vol. 46, no. 2, pp. 62–67, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Rahbarimanesh, M. Ehsani, M. Karahroudi et al., “Cytomegalovirus disease in children with acute lymphoblastic leukemia in the nontransplant setting: case series and review of the literature,” Journal of Pediatric Hematology/Oncology, vol. 37, no. 6, pp. 429–432, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. K. K. Biron, “Antiviral drugs for cytomegalovirus diseases,” Antiviral Research, vol. 71, no. 2-3, pp. 154–163, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. S. Kraft, W. S. Armstrong, and A. M. Caliendo, “Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective,” Clinical Infectious Diseases, vol. 54, no. 12, pp. 1793–1797, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Hirayama, S. Sakamaki, Y. Tsuji et al., “Recovery of neutrophil count by ganciclovir in patients with chronic idiopathic neutropenia associated with cytomegalovirus infection in bone marrow stromal cells,” International Journal of Hematology, vol. 79, no. 4, pp. 337–339, 2004. View at Publisher · View at Google Scholar
  23. W. D. Roberts, K. I. Weinberg, D. B. Kohn, L. Sender, R. Parkman, and C. Lenarsky, “Granulocyte recovery in pediatric marrow transplant recipients treated with ganciclovir for cytomegalovirus infection,” American Journal of Pediatric Hematology/Oncology, vol. 15, no. 3, pp. 320–323, 1993. View at Google Scholar
  24. S. Jeon, W. K. Lee, Y. Lee, D. G. Lee, and J. W. Lee, “Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation,” Ophthalmology, vol. 119, no. 9, pp. 1892–1898, 2012. View at Publisher · View at Google Scholar · View at Scopus